TITLE

Duodenal Ulcer and Recurrent Dyspepsia

AUTHOR(S)
Hodgkin, G. K. H.; Freedman, R.; Fuller, I.; Whewell, J.
PUB. DATE
August 1970
SOURCE
British Medical Journal;8/15/1970, Vol. 3 Issue 5719, p368
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64097663

 

Related Articles

  • Perforated duodenal ulcer.  // British Medical Journal;8/28/1976, Vol. 2 Issue 6034, p489 

    Evaluates the adversity of perforated duodenal ulcer in women. Number of women affected with duodenal ulcer; Association of a recurrent perforation; Techniques of operation.

  • Potential causes of heartburn. Hashmi, Taqi // Independent Nurse;6/1/2009, p39 

    The article discusses heartburn, dyspepsia, and the gastrointestinal (GI) disorders that may cause them. The GI disorders that are primarily associated with the symptoms of heartburn or dyspepsia include gastric reflux disease (GORD), peptic ulcer, and non-ulcer dyspepsia. The author explores...

  • Tips from Other Journals.  // American Family Physician;3/1/2000, Vol. 61 Issue 5, p1452 

    Offers several health tips. Effect of calcium supplements on fetal bone mineralization; Treatment of giant duodenal ulcers with omeprazole; Diagnosis and treatment of nonulcer dyspepsia.

  • Intermittent treatment of duodenal ulcer with cimetidine. Dev Bardhan, Karna // British Medical Journal;7/5/1980, Vol. 281 Issue 6232, p20 

    Evaluates the intermittent treatment of duodenal ulcer with short courses of cimetidine. Administration of cimetidine as an alternative to maintenance treatment; Confirmation on the recurrence of the ulcer and subsequent healing through gastroscopy; Prevention on the recurrence of duodenal ulcer.

  • Do Helicobacter pylori-Positive Duodenal Ulcers Have an Increased Risk of Bleeding? Kadayifci, Abdurrahman; Simsek, Halis // American Journal of Gastroenterology;Oct1995, Vol. 90 Issue 10, p1901 

    Presents a letter to the editor about Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer and ulcer recurrence.

  • Adenomyoma of the Duodenum. Altan, Ege; Köklü, Seyfettin; Özmen, Mahir; Büyükeren, Berrin; Gedikoğlu, Gökhan // American Journal of Gastroenterology;Aug2015, Vol. 110 Issue 8, p1141 

    The article presents a case study of a 62-year-old man with history recurrent epigastric pain and dyspepsia who was diagnosed with duodenal adenomyoma.

  • Why does rebound abdominal pain occur after anti-ulcer drugs are stopped? Long, R.G. // BMJ: British Medical Journal (International Edition);05/03/97, Vol. 314 Issue 7090, p1345 

    Discusses the reason why rebound abdominal pain occur after anti-ulcer drugs are stopped. Causes on non-ulcer dyspepsia; Association of areas of endoscopic gastritis or duodenitis with epigastric pain; Secretion of gastrin.

  • Prevention of duodenal ulcer recurrence. Strum, Williamson B.; Strum, W B // Annals of Internal Medicine;Nov86, Vol. 105 Issue 5, p757 

    Recurrent duodenal ulcers, treated with cimetidine, 400 mg, or ranitidine, 150 mg, once nightly, or with sucralfate, 1 g twice daily, can be prevented in approximately 75% of patients for up to 1 year. Because these drugs are generally of equal efficacy, the choice is based on the patient's...

  • Management of Helicobacter pylori infection. Harris, Adam; Misiewicz, J J // BMJ: British Medical Journal (International Edition);11/3/2001, Vol. 323 Issue 7320, p1047 

    Discusses management of Helicobacter pylori infection in patients with dyspepsia with or without endoscopic abnormalities. Eradication treatment for duodenal ulcer resulting from H pylori infection; Diagnosis and treatment of gastric ulcers; Interaction between H pylori and gastro-oesophageal...

  • MEDICAL MANAGEMENT OF PEPTIC ULCER∗. Flood, Charles // American Journal of Gastroenterology;May1957, Vol. 27 Issue 5, p457 

    Discusses research being done on the medical management of patients with peptic ulcer. Association of ulcer recurrence with complications; Duration of the healing time of duodenal ulcer; Use of animal experimentation in the evaluation of the efficacy of medical therapy for ulcer.

Share

Read the Article

Other Topics